Insulin Detemir (TP-005CL)

Insulin detemir is a long-acting human insulin analogue used to maintain basal levels of insulin in diabetic individuals. It is produced using recombinant DNA technology in yeast cells. This insulin analogue has a 14-C fatty acid, myristic acid, bound to the lysine amino acid at position B29. The myristoyl side chain increases self-association and albumin binding. This along with slow systemic absorption from the injection site prolongs distribution of the hormone into tissues and results in a long duration of action. Novo Nordisk markets insulin detemir under the trade name Levemir.      

Protein therapeutics replacing a protein that is deficient or abnormal: Endocrine disorders (hormone deficiencies)
Insulin detemir; insulin glargine
Trade Name
Levemir (Detemir), Lantus (Glargine)
Insulin analogues with slower onset of action and longer duration of action
Examples of Clinical Use
Diabetes mellitus
Insulin detemir, Insulin detemir recombinant, Levemir, Levemir flexpen, Levemir innolet, Levemir penfill, NN-304

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-381-2994    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2018 Creative-Biolabs All Rights Reserved